Sylvester appoints prominent oncologist-researcher to lead transplantation and cellular therapy
Damian Green, MD, who joins Sylvester Cancer in March, will also help lead translational research
2024-02-16
(Press-News.org) MIAMI, FLORIDA (Feb. 15, 2024) – Prominent oncologist and researcher Damian Green, M.D., will join Sylvester Comprehensive Cancer Center at the University Miami Miller School of Medicine this spring to lead its transplantation and cellular therapy services.
Green will serve as chief of Sylvester’s Division of Transplantation & Cellular Therapy, as well as assistant director of Translational Research, beginning March 1. He joins Sylvester from Fred Hutchinson Cancer Center in Seattle, where he built a distinguished track record in research and clinical practice treating blood cancers.
Green specializes in multiple myeloma and other B-cell malignancies, and his research has led to the discovery and testing of several pioneering immunotherapy approaches to treat myeloma and other blood cancers.
“Damian has a long track record of innovative and groundbreaking approaches to immunotherapy by improving cellular and antibody-based approaches for patients with multiple myeloma or lymphoma. He is superbly qualified to assume leadership of our outstanding transplantation and cellular therapy efforts, and his research mentorship will elevate our training of the next generation of physician scientists,” said Stephen Nimer, M.D., director of Sylvester Comprehensive Cancer Center, Oscar de la Renta Endowed Chair in Cancer Research and executive dean for research at the Miller School. “We are thrilled to have Damian join our growing team of cancer research experts at Sylvester; his pioneering work in the field of stem cell transplantation and cellular therapies combined with his thoughtful approach to cancer care will touch many patients’ lives.”
Green plans to use his expertise and experience treating and researching multiple myeloma, lymphoma and related cancers to help expand Sylvester’s impactful work in immunotherapy for blood cancers.
“Sylvester is an amazing cancer center with remarkable people and very strong programs,” he said. “I’m thrilled to be part of the center’s growth and to help contribute more broadly to the field of cancer discovery.”
Besides multiple myeloma, Green’s clinical expertise includes lymphomas, amyloidosis, immunotherapy and stem cell transplants for blood cancers. His research focuses on developing immunotherapeutic approaches to treat and ultimately eradicate multiple myeloma and lymphoma.
At Fred Hutch, Green served as a professor in its translation science and therapeutics division, and an associate professor at the University of Washington (UW) School of Medicine. He also was deputy director for myeloma at the Seattle Translational Tumor Registry.
Prior to joining Fred Hutch, Green attended medical school and completed his residency in internal medicine at The Ohio State University College of Medicine, where he was chief resident in 2004. He completed his medical oncology fellowship at Fred Hutch and UW in 2007.
on the InventUM blog and follow @SylvesterCancer on X for the latest news on Sylvester’s research and care.
# # #
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-02-16
By Wynne Parry
WOODS HOLE, Mass. – Like humans struggling to get through the COVID-19 pandemic, bacterial cells need social distancing to thwart viruses. But in some situations, such as inside elevators or within the candy-colored bacterial structures known as “pink berries,” staying apart just isn’t feasible.
Looking like spilled Nerds or Pop Rocks, the communal, multicellular pink berries litter the submerged surface of salt marshes in and around Woods Hole. New research conducted at the Marine Biological ...
2024-02-16
Hospital-acquired acute kidney injury (HA-AKI) is a common complication in hospitalized patients that can lead to chronic kidney disease and is associated with longer hospital stays, higher health care costs and increased mortality. Given these negative consequences, preventing HA-AKI can improve hospitalized patient outcomes. However, anticipating HA-AKI onset is difficult due to a large number of contributing factors involved.
Researchers from Mass General Brigham Digital tested a commercial machine learning tool, the Epic Risk of HA-AKI predictive model, and found it was moderately successful at predicting risk of HA-AKI in recorded patient data. ...
2024-02-16
(Toronto, February 16, 2024) JMIR Publications is pleased to announce that JMIR Bioinformatics and Biotechnology has passed the Scientific Quality Review by the US National Library of Medicine (NLM) for PubMed Central (PMC). This decision reflects the scientific and editorial quality of the journal. All articles published from 2022 onward will be found on PMC and PubMed after their technical evaluation.
Launched in 2020, JMIR Bioinformatics and Biotechnology is a sister journal of Journal of Medical Internet Research ...
2024-02-16
Standard chemotherapy regimens, which are mostly based on testing in relatively young and healthy patients, may do more harm to older adults with cancer who often struggle with other health issues. New research, published yesterday in JAMA Network Open, shows that lowering the dose and adjusting the schedule of how chemotherapy is given to older adults with advanced cancer can make life better for patients, without compromising their treatment goals.
The study, which was led by researchers from the University of Rochester Medical Center’s Wilmot Cancer Institute, focuses on how well older people tolerate chemotherapy. More than 30 percent of patients benefitted from treatment regimen ...
2024-02-16
HOUSTON – (Feb. 16, 2024) – Rice University computer science researchers have found bias in widely used machine learning tools used for immunotherapy research.
Ph.D. students Anja Conev, Romanos Fasoulis and Sarah Hall-Swan, working with computer science faculty members Rodrigo Ferreira and Lydia Kavraki, reviewed publicly available peptide-HLA (pHLA) binding prediction data and found it to be skewed toward higher-income communities. Their paper examines the way that biased data input affects the algorithmic recommendations being ...
2024-02-16
A study co-led by Professor Kelly Metcalfe of the Lawrence Bloomberg Faculty of Nursing, and researchers at the Familial Breast Cancer Research Unit at Women’s College Hospital, finds risk-reducing mastectomies (RRM) in women with a BRCA1 or BRCA2 genetic variant, significantly reduces the risk of being diagnosed with breast cancer and lowers the probability of death.
The study, published in the British Journal of Cancer, examined how RRM affects the rate of death of women with a pathogenic variant but no cancer diagnosis. To date, there has been only one other study published by researchers in the Netherlands that examines the impact ...
2024-02-16
The Hope Foundation for Cancer Research, the public charity supporting SWOG Cancer Research Network, has recently established the Frank and Linda Meyskens Annual Endowed Lectureship on Advances in Cancer Prevention. Since the early 1980’s, Dr. Meyskens has been a leader in the recognition, development, and clinical usage of Prevention in the management of cancer. Frank and Linda have directed the development of this lectureship to advance the explosion of knowledge that is expanding opportunities to engage Prevention in personalized medicine, including early detection and genetically ...
2024-02-16
A female White-eared opossum (Didelphis albiventris) found dead in 2021 in Bosque dos Jequitibás Park in the center of Campinas, one of the largest cities in São Paulo state, Brazil, died from rabies meningoencephalitis, according to a group of researchers at the University of São Paulo (USP) and Adolfo Lutz Institute (IAL), the regional reference laboratory, working with health professionals affiliated with public institutions in São Paulo city and Campinas.
Reported in an article published in the journal Emerging Infectious Diseases, the finding serves as an alert to the presence of the virus, which is deadly to humans, ...
2024-02-16
Researchers led by Northwestern University and the University of Wisconsin-Madison have introduced a pioneering approach aimed at combating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and Amyotrophic lateral sclerosis (ALS).
In a new study, researchers discovered a new way to enhance the body’s antioxidant response, which is crucial for cellular protection against the oxidative stress implicated in many neurodegenerative diseases.
The study published today (Feb. 16) in the journal Advanced Materials.
Nathan Gianneschi, the Jacob & Rosaline Cohn Professor of Chemistry at Northwestern’s Weinberg ...
2024-02-16
(Santa Barbara, Calif.) — Anoxic marine basins may be among the most viable places to conduct large-scale carbon sequestration in the deep ocean, while minimizing negative impacts to marine life. So say UC Santa Barbara researchers in a paper published in the journal AGU Advances. As we explore ways to actively draw down the levels of carbon in the atmosphere, sending plant biomass to these barren, oxygen-free zones on the seafloor becomes an option worth considering.
“The big picture here is that all the best models that we have say that we have to do some form of net negative CO2 removal in order to hit climate goals,” said geochemist, geobiologist ...
LAST 30 PRESS RELEASES:
[Press-News.org] Sylvester appoints prominent oncologist-researcher to lead transplantation and cellular therapy
Damian Green, MD, who joins Sylvester Cancer in March, will also help lead translational research
